Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development

Journal of Cellular Biochemistry

Volumn 101, Issue 5, 2007, Pages 1222-1237

  Huh, Man Il ^a   Lee, Young Mi ^a   Seo, Ng Kyung ^a   Kang, Bong Seok ^b   Chang, Yongmin ^c   Lee, Young Sup ^a   Fini, M Elizabeth ^d   Kang, Shin Sung ^a   Jung, Jae Chang ^a  

^a Kyungpook National University   (South Korea)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Kyungpook National University School of Medicine   (South Korea)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

ADAM10; CD44v6; Cell migration; Corneal development; Ectodomain cleavage; Extracellular matrix; Matrix metalloproteinases; MT3 MMP

Indexed keywords

ADAM PROTEIN; CD44V6 ANTIGEN; COLLAGEN FIBER; COLLAGEN TYPE 9; COLLAGENASE 3; GELATINASE A; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SWELLING; CHICK EMBRYO; CORNEA; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ANALYSIS; EYE DEVELOPMENT; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD44; CELL MOVEMENT; CHICKENS; CORNEA; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOPROTEINS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 34547917186     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21246     Document Type: Article

References (76)

1. Akimoto Y, Yamakawa N, Furukawa K, Kimata K, Kawakami H, Hirano H. 2002. Changes in distribution of the long form of type XII collagen during chicken corneal development. J Histochem Cytochem 50:851-862.
2. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP, Werb Z. 1996. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122:1723-1736.
3. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knauper V, Docherty AJ, Murphy G. 2000. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett 473:275-279.
4. Bard JB, Hay ED. 1975. The behavior of fibroblasts from the developing avian cornea. Morphology and movement in situ and in vitro. J Cell Biol 67:400-418.
5. Bond M, Murphy G, Bennett MR, Amour A, Knauper V, Newby AC, Baker AH. 2000. Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J Biol Chem 275:41358-41363.
6. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP, Murphy G. 1998. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273:871-880.
7. Buttner FH, Hughes CE, Margerie D, Lichte A, Tschesche H, Caterson B, Bartnik E. 1998. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. Biochem J 333(Pt 1):159-165.
8. Cai DH, Brauer PR. 2002. Synthetic matrix metalloproteinase inhibitor decreases early cardiac neural crest migration in chicken embryos. Dev Dyn 224:441-449.
9. Cai CX, Linsenmayer TF. 2001. Nuclear translocation of ferritin in corneal epithelial cells. J Cell Sci 114:2327-2334.
10. Cichy J, Pure E. 2003. The liberation of CD44. J Cell Biol 161:839-843.
11. Corbel C, Lehmann A, Davison F. 2000. Expression of CD44 during early development of the chick embryo. Mech Dev 96:111-114.
12. Coulombre AJ, Coulombre JL. 1958. Corneal development. I. Corneal transparency. J Cell Physiol 51:1-11.
13. Coulombre AJ, Coulombre JL. 1964. Corneal development. 3. The role of the thyroid in dehydration and the development of transparency. Exp Eye Res 75:105-114.
14. Cowell S, Knauper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, Lopez-Otin C, Reynolds JJ, Murphy G. 1998. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: Associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 331(Pt 2):453-458.
15. D'Angelo M, Yan Z, Nooreyazdan M, Pacifici M, Sarment DS, Billings PC, Leboy PS. 2000. MMP-13 is induced during chondrocyte hypertrophy. J Cell Biochem 77:678-693.
16. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250:751-757.
17. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY. 2001. MT1-MMP initiates activation of pro-MMP-2 and integrin alphav-beta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263:209-223.
18. Doane KJ, Ting WH, McLaughlin JS, Birk DE. 1996. Spatial and temporal variations in extracellular matrix of periocular and corneal regions during corneal stromal development. Exp Eye Res 62:271-283.
19. Doane KJ, Bhattacharya R, Marchant J. 2002. Pertubation of beta1 integrin function using anti-sense or function-blocking antibodies on corneal cells grown on fibronectin and tenascin. Cell Biol Int 26:131-144.
20. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161-174.
21. Fini ME, Cook JR, Mohan R. 1998a. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res 290(Suppl 14):S12-S23.
22. Fini ME, Cook JR, Mohan R, Brinckerhoff CE. 1998b. Regulation of metrix metalloproteinase gene expression. In: Parks WC, Mecharm RP, editors. Matrix metalloproteinases. New York: Academic Press, pp 299-356.
23. Fitch JM, Fini ME, Beebe DC, Linsenmayer TF. 1998. Collagen type IX and developmentally regulated swelling of the avian primary corneal stroma. Dev Dyn 212:27-37.
24. Fitch JM, Kidder JM, Linsenmayer TF. 2005. Cellular invasion of the chicken corneal stroma during development: Regulation by multiple matrix metalloproteases and the lens. Dev Dyn 232:106-118.
25. Fosang AJ, Last K, Fujii Y, Seiki M, Okada Y. 1998. Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain. FEBS Lett 430:186-190.
26. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. 1997. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 74:111-122.
27. Hall RJ, Erickson CA. 2003. ADAM 10: An active metalloprotease expressed during avian epithelial morphogenesis. Dev Biol 256:146-159.
28. Hartmann D, de Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W, Umans L, Lubke T, Lena Illert A, von Figura K, Saftig P. 2002. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet 11:2615-2624.
29. Hay ED. 1979. Development of the vertebrate cornea. Int Rev Cytol 63:263-322.
30. Hay ED, Revel JP. 1969. Fine structure of the developing avian cornea. Monogr Dev Biol 1:1-144.
31. Hendrix MJ, Hay ED, von der Mark K, Linsenmayer TF. 1982. Immunohistochemical localization of collagen types I and II in the developing chick cornea and tibia by electron microscopy. Invest Ophthalmol Vis Sci 22:359-375.
32. Hoegy SE, Oh HR, Corcoran ML, Stetler-Stevenson WG. 2001. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J Biol Chem 276:3203-3214.
33. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
34. Isacke CM, Yarwood H. 2002. The hyaluronan receptor, CD44. Int J Biochem Cell Biol 34:718-721.
35. Jung JC, Leco KJ, Edwards DR, Fini ME. 2002. Matrix metalloproteinases mediate the dismantling of mesenchymal structures in the tadpole tail during thyroid hormone-induced tail resorption. Dev Dyn 223:402-413.
36. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. 2001. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153:893-904.
37. Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A, Delaisse JM, Foged NT. 2002. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277:44061-44067.
38. Kashiwagi M, Tortorella M, Nagase H, Brew K. 2001. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem 276:12501-12504.
39. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. 1995. CD44 isoforms in prognosis of breast cancer. Lancet 346:502.
40. Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131.
41. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, Zardi L, Murphy G. 1997. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272:7608-7616.
42. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. 2000. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148:615-624.
43. Marchant JK, Zhang G, Birk DE. 2002. Association of type XII collagen with regions of increased stability and keratocyte density in the cornea. Exp Eye Res 75:683-694.
44. Mitchell BS, Whitehouse A, Prehm P, Delpech B, Schumacher U. 1996. CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formation. Clin Exp Metastasis 14:107-114.
45. Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M. 2002. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21:3949-3959.
46. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL. 2002. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol 157:493-507.
47. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, Iwatsubo T, Nakajima M, Shinohara M, Saya H. 2004. Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 165:893-902.
48. Nagase H. 1998. Stromelysins 1 and 2. In: Parks WC, Mecharm RP, editors. Matrix metalloproteinases. New York: Academic Press, pp 43-84.
49. Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
50. Naor D, Sionov RV, Ish-Shalom D. 1997. CD44: Structure, function, and association with the malignant process. Adv Cancer Res 71:241-319.
51. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272:2446-2451.
52. Okamoto I, Kawano Y, Tsuiki H, Sasaki J, Nakao M, Matsumoto M, Suga M, Ando M, Nakajima M, Saya H. 1999. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 18:1435-1446.
53. Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, Holgado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Guha A, Matsumoto M, Ushio Y, Saya H, Wong AJ. 2002. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol 160:441-447.
54. Okumura Y, Sato H, Seiki M, Kido H. 1997. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett 402:181-184.
55. Perris R. 1997. The extracellular matrix in neural crest-cell migration. Trends Neurosci 20:23-31.
56. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164:769-779.
57. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65.
58. Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler Stevenson WG, Seiki M. 1996. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett 385:238-240.
59. Seiki M. 1999. Membrane-type matrix metalloproteinases. Apmis 107:137-143.
60. Shofuda K, Yasumitsu H, Nishihashi A, Miki K, Miyazaki K. 1997. Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain. J Biol Chem 272:9749-9754.
61. Siegler V, Quantock AJ. 2002. Two-stage compaction of the secondary avian cornea during development. Exp Eye Res 74:427-431.
62. Singh R, Campbell BJ, Yu LG, Fernig DG, Milton JD, Goodlad RA, FitzGerald AJ, Rhodes JM. 2001. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology 11:587-592.
63. Smith KM, Gaultier A, Cousin H, Alfandari D, White JM, DeSimone DW. 2002. The cysteine-rich domain regulates ADAM protease function in vivo. J Cell Biol 159:893-902.
64. Soukka T, Salmi M, Joensuu H, Hakkinen L, Sointu P, Koulu L, Kalimo K, Klemi P, Grenman R, Jalkanen S. 1997. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells. Cancer Res 57:2281-2289.
65. Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516.
66. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338.
67. Svoboda KK, Nishimura I, Sugrue SP, Ninomiya Y, Olsen BR. 1988. Embryonic chicken cornea and cartilage synthesize type IX collagen molecules with different amino-terminal domains. Proc Natl Acad Sci USA 85:7496-7500.
68. Thorne RF, Legg JW, Isacke CM. 2004. The role of the CD44 transmembrane and cytoplasmic domains in coordinating adhesive and signalling events. J Cell Sci 117:373-380.
69. Toole BP, Trelstad RL. 1971. Hyaluronate production and removal during corneal development in the chick. Dev Biol 26:28-35.
70. Toth M, Chvyrkova I, Bernardo MM, Hernandez-Barrantes S, Fridman R. 2003. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: Role of TIMP-2 and plasma membranes. Biochem Biophys Res Commun 308:386-395.
71. Trelstad RL, Coulombre AJ. 1971. Morphogenesis of the collagenous stroma in the chick cornea. J Cell Biol 50:840-858.
72. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST. 1993. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756.
73. Wu JJ, Lark MW, Chun LE, Eyre DR. 1991. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 266:5625-5628.
74. Young BB, Zhang G, Koch M, Birk DE. 2002. The roles of types XII and XIV collagen in fibrillogenesis and matrix assembly in the developing cornea. J Cell Biochem 87:208-220.
75. Yu Q, Stamenkovic I. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14:163-176.
76. Zhao H, Bernardo MM, Osenkowski P, Sohail A, Pei D, Nagase H, Kashiwagi M, Soloway PD, DeClerck YA, Fridman R. 2004. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 activation. J Biol Chem 279:8592-8601.